Published in Mol Endocrinol on May 01, 2001
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A (2003) 2.23
Integrated morphodynamic signalling of the mammary gland. Nat Rev Mol Cell Biol (2011) 1.50
Vascular Robo4 restricts proangiogenic VEGF signaling in breast. Proc Natl Acad Sci U S A (2010) 1.15
Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia (2010) 1.07
Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol (2009) 1.04
Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth. J Cell Biochem (2011) 0.94
VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis. Am J Pathol (2010) 0.87
STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis. J Biol Chem (2013) 0.87
Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies. BMC Cancer (2010) 0.81
16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo. Horm Cancer (2010) 0.76
Regeneration of Bovine Mammary Gland in Immunodeficient Mice by Transplantation of Bovine Mammary Epithelial Cells Mixed with Matrigel. Int J Stem Cells (2016) 0.75
Autocrine effect of vascular endothelial growth factor-A is essential for mitochondrial function in brown adipocytes. Metabolism (2015) 0.75
RhoGTPase stimulation is associated with strontium chloride treatment to counter simulated microgravity-induced changes in multipotent cell commitment. NPJ Microgravity (2017) 0.75
C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol (2000) 2.11
Effects of inhibition of basement membrane collagen deposition on rat mammary gland development. Dev Biol (1980) 1.79
Prolactin synthesis and secretion by human breast cancer cells. Cancer Res (1995) 1.49
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J Clin Pathol (2001) 1.36
Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A (1998) 1.31
Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous. Dev Biol (1999) 1.27
Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer (1998) 1.25
Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology (1979) 1.22
Saturation of, and competition for entry into, the apical secretory pathway. Proc Natl Acad Sci U S A (2000) 1.20
Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice. Cancer Res (1984) 1.17
Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev Dyn (2001) 1.13
Concerning the necessary coupling of development to proliferation of mouse mammary epithelial cells. J Biol Chem (1973) 1.11
A role of estrogen/ERalpha signaling in BRCA1-associated tissue-specific tumor formation. Oncogene (2007) 1.10
Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol (2001) 1.08
Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol (2000) 1.07
Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology (2003) 1.05
Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res (1987) 1.04
Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene (2008) 1.03
Techniques for studying development of normal mammary epithelial cells in organ culture. Methods Enzymol (1975) 1.03
Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene (2007) 1.00
Regulated heat shock protein 27 expression in human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2001) 1.00
Epidermal growth factor stimulates the growth of A431 tumors in athymic mice. Cancer Lett (1985) 1.00
Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol (2003) 1.00
Cloning and characterization of a novel orphan G-protein-coupled receptor localized to human chromosome 2p16. Biochem Biophys Res Commun (1999) 0.99
Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1. J Cell Physiol (2009) 0.98
Prolactin as a mitogen in mammary cells. J Mammary Gland Biol Neoplasia (1997) 0.97
Solubilization of active prolactin receptors by a nondenaturing zwitterionic detergent. J Biol Chem (1982) 0.97
Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol Endocrinol (1995) 0.97
Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res (1987) 0.96
Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas. Endocrine (2000) 0.96
Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res (1990) 0.94
Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene (1996) 0.94
Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat (1996) 0.94
A role of the cell cycle in hormone-dependent differentiation. J Cell Biol (1974) 0.92
An early effect of prolactin on the formation of -lactalbumin by mouse mammary epithelial cells. J Biol Chem (1973) 0.92
Some aspects of mouse mammary gland development from maturity to early pregnancy. In Vitro (1973) 0.92
Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience (1995) 0.91
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer (2010) 0.89
Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer (1993) 0.88
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells. Int J Cancer (2000) 0.86
Difference between mammary epithelial cells from mature virgin and primiparous mice. Cancer Res (1978) 0.86
Thyroid hormone regulation of prolactin binding to mouse mammary glands. Biochem Biophys Res Commun (1979) 0.86
Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol (2008) 0.85
Functional differentiation in mouse mammary gland epithelium is attained through DNA synthesis, inconsequent of mitosis. Dev Biol (1981) 0.85
Purification of a prolactin receptor. Proc Natl Acad Sci U S A (1982) 0.85
Phospholipid methylation stimulates lactogenic binding in mouse mammary gland membranes. Proc Natl Acad Sci U S A (1979) 0.84
Crystallization and preliminary x-ray characterization of bovine growth hormone. Purification of bovine prolactin and growth hormone. J Biol Chem (1985) 0.84
Regulation of development of the normal mammary gland by hormones and growth factors. Cancer Treat Res (1988) 0.83
Studies on the mechanism by which thyroid hormones enhance alpha-lactalbumin activity in explants from mouse mammary glands. Endocrinology (1977) 0.83
Role of growth hormone and insulin-like growth factor-I in mammary development. Endocrinology (1993) 0.83
Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Exp Eye Res (2002) 0.82
Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line. Cancer Res (1989) 0.82
Membrane modification differentially affects the binding of the lactogenic hormones human growth hormone and ovine prolactin. Proc Natl Acad Sci U S A (1981) 0.81
Characteristics of a membrane-associated antilactogen binding site for tamoxifen. Mol Cell Endocrinol (1993) 0.81
A role of thyroid hormones in differentiation of mouse mammary gland in vitro. Biochem Biophys Res Commun (1975) 0.81
Cellular distribution of prolactin receptors in human digestive tissues. J Clin Endocrinol Metab (1996) 0.81
Isolation, characterization, and regulation of the prolactin receptor. J Dairy Sci (1985) 0.80
Super-active forms of placental lactogen and prolactin. Biochem Biophys Res Commun (1974) 0.80
Bifunctional activity of epidermal growth factor on alpha- and kappa-casein gene expression in rodent mammary glands in vitro. Endocrinology (1986) 0.80
Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production. Cancer Res (1981) 0.80
Effect of thyroid status on development of spontaneous mammary tumors in primiparous C3H mice. Cancer Res (1982) 0.80
The heterogeneity of soluble estrogen receptors from rat uteri and their modification by temperature, imidazole compounds and estradiol. Biochim Biophys Acta (1970) 0.79
Critical cell proliferation as a prerequisite for differentiation of mammary epithelial cells. Enzyme (1973) 0.79
Mutational analysis of the PRL receptor gene in human breast tumors with differential PRL receptor protein expression. J Clin Endocrinol Metab (2001) 0.79
Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology (1993) 0.79
Transplacental action of diethylstilbestrol on reproductive and endocrine organs, mammary glands, and serum hormone levels in two- and nine-month-old female rats. Cancer Res (1983) 0.79
Transduction of the herpes thymidine kinase gene into premalignant murine mammary epithelial cells renders subsequent breast cancers responsive to ganciclovir therapy. Hum Gene Ther (1996) 0.78
Stimulation of growth of human breast cancer cells (T47D) by platelet derived growth factor. Cancer Lett (1991) 0.78
Induction of cryptic lactogenic hormone binding in livers of adult female mice treated neonatally with estradiol or nafoxidine. Endocrinology (1982) 0.78
Characterization of Δ7/11, a functional prolactin-binding protein. J Mol Endocrinol (2012) 0.78
Thyroid hormones enhance the synthesis and secretion of alpha-lactalbumin by mouse mammary tissue in vitro. Endocrinology (1984) 0.78
Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol (1981) 0.78
Involution of mouse mammary glands in whole organ culture: a model for studying programmed cell death. Biochem Biophys Res Commun (1995) 0.78
An insulin derivative with biological activity greater than that of native insulin. J Cell Physiol (1976) 0.78
Thyroid hormone regulation of epidermal growth factor receptor levels in mouse mammary glands. Endocrinology (1986) 0.77
Prolactin-induced protein kinase C activity in a mouse mammary cell line (NOG-8). Mol Cell Endocrinol (1992) 0.77
Tamoxifen inhibition of prolactin action in the mouse mammary gland. Endocrinology (1991) 0.77
Dissociation of cytological and functional differential in virgin mouse mammary gland during inhibition of DNA synthesis. J Cell Sci (1982) 0.77
Detection of messenger RNA for gonadotropin-releasing hormone (GnRH) but not for GnRH receptors in mouse mammary glands. Biochem Biophys Res Commun (1995) 0.77
Vanadate disrupts mammary gland development in whole organ culture. Dev Dyn (2001) 0.76
Tamoxifen inhibits prolactin signal transduction in ER - NOG-8 mammary epithelial cells. Cancer Lett (1997) 0.76
16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo. Horm Cancer (2010) 0.76
Interaction of concanavalin A with lactogenic receptors in isolated membranes. Arch Biochem Biophys (1982) 0.76
Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer. Br J Cancer (2003) 0.76
Milk protein synthesis by mammary glands of vitamin D-deficient mice. Endocrinology (1987) 0.76
The regulation of mammary prolactin receptor metabolism by a retroviral envelope protein. J Mol Endocrinol (1997) 0.76
CXCR4 expression in vitreoretinal membranes. Br J Ophthalmol (2003) 0.75
Paracrine action of keratinocyte growth factor (KGF) during ruminant mammogenesis. Mol Cell Endocrinol (2001) 0.75
Requirement of essential fatty acids in the diet for development of the mouse mammary gland. J Natl Cancer Inst (1980) 0.75
Lactose synthetase activity in mouse mammary glands is controlled by thyroid hormones. J Cell Biol (1979) 0.75
Gene expression of gonadotropin-releasing hormone in early pregnant rat and steroid hormone exposed mouse uteri. J Endocrinol Invest (1996) 0.75
Characterization of super-active insulin, prolactin and placental lactogen. Biochem Biophys Res Commun (1975) 0.75
Stressor-specific increase of vasopressin mRNA in paraventricular hypophysiotrophic neurons. Neurosci Lett (1994) 0.75
Ruminants express a prolactin receptor of M(r) 33,000-36,000 in the mammary gland throughout pregnancy and lactation. J Endocrinol (1993) 0.75
Purification and characterization of mouse alpha-lactalbumin from lactating mammary glands. Biochim Biophys Acta (1983) 0.75
Dedication. Yale J. Topper (1916-1995). J Mammary Gland Biol Neoplasia (1997) 0.75
Thyroid hormone regulation of alpha-lactalbumin: differential glycosylation and messenger ribonucleic acid synthesis in mouse mammary glands. Endocrinology (1988) 0.75
The subunit character of soluble estrogen receptors from rat uteri and their modification in vitro. Biochim Biophys Acta (1970) 0.75